Samokhvalov, Andriy V. http://orcid.org/0000-0001-6091-3045
Probst, Charlotte
Awan, Saima
George, Tony P.
Le Foll, Bernard
Voore, Peter
Rehm, Jürgen
Article History
Received: 2 January 2018
Accepted: 29 May 2018
First Online: 13 June 2018
Ethics approval and consent to participate
: The DA VINCI project was a clinical implementation project. As such, patients receiving treatment through the DA VINCI project were not required to provide consent for participation in a research project. The data for this study were obtained through a clinical chart review approved by the Centre for Addiction and Mental Health Research Ethics Board (Protocol #053-2016).
: Dr. George has served on Data Safety and Monitoring Boards for Novartis, and has had a grant and contract funding from Pfizer in the past 2 years. Dr. Le Foll has received grant and salary support from Pfizer and Bioprojet. He received speaker fees or has been consultant for Richter Pharmaceuticals, Lundbeck, Ethypharm, Mettrum and Allergan. Drs. George, Le Foll and Rehm held multiple grants from CIHR, NIH and other organizations. None of these activities are related to this study, thus the authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.